DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 74 filers reported holding DERMA SCIENCES INC in Q2 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,857,000 | +84.0% | 549,341 | +65.2% | 0.02% | +80.0% |
| Q3 2016 | $1,553,000 | +69.5% | 332,521 | +43.0% | 0.01% | +66.7% |
| Q2 2016 | $916,000 | +24.5% | 232,521 | -2.1% | 0.01% | +20.0% |
| Q1 2016 | $736,000 | -32.2% | 237,507 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $1,085,000 | +4.0% | 237,507 | +7.2% | 0.01% | 0.0% |
| Q3 2015 | $1,043,000 | -62.9% | 221,507 | -43.6% | 0.01% | -50.0% |
| Q2 2015 | $2,810,000 | -3.2% | 392,500 | +14.6% | 0.01% | +9.1% |
| Q1 2015 | $2,902,000 | +92.3% | 342,600 | +111.4% | 0.01% | +120.0% |
| Q4 2014 | $1,509,000 | +229.5% | 162,100 | +194.7% | 0.01% | +150.0% |
| Q3 2014 | $458,000 | -28.0% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $636,000 | -8.8% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $697,000 | +17.1% | 55,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $595,000 | – | 55,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
| Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
| Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
| Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
| DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
| Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
| THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
| EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |